These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7306401)

  • 1. Effects of chronic haloperidol and sulpiride treatment on rat nigral GABA content.
    Rampello L; Giammona G; Patti F; Reggio A; Nicoletti F; Di Giorgio RM; Condorelli DF
    Boll Soc Ital Biol Sper; 1981 Aug; 57(15):1608-11. PubMed ID: 7306401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of chronic haloperidol and sulpiride treatment on nigral and striatal GABA content.
    Nicoletti F; Patti F; Condorelli DF; Rampello L; Giammona G; Di Giorgio RM; Canonico PL; Scapagnini U
    J Neurochem; 1981 Oct; 37(4):1048-51. PubMed ID: 7320718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of prolactin in sulpiride-induced changes in nigral and striatal GAD activity.
    Scapagnini U; Canonico PL; Patti F; Condorelli DF; Nicoletti F
    Ann Ist Super Sanita; 1982; 18(1):27-9. PubMed ID: 7171172
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological influences on the brain level and transport of GABA. II) Effect of various psychoactive drugs on brain level and uptake of GABA].
    Gabana MA; Varotto M; Saladini M; Zanchin G; Battistin L
    Boll Soc Ital Biol Sper; 1981 Apr; 57(8):909-13. PubMed ID: 7272066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.
    Porceddu ML; Giorgi O; Ongini E; Mele S; Biggio G
    Life Sci; 1986 Jul; 39(4):321-8. PubMed ID: 3526066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different doses of apomorphine on GAD activity in rat substantia nigra.
    Condorelli DF; Giammona G; Patti F; Nicoletti F; Rampello L; Reggio A; Matera M; Di Giorgio RM
    Ital J Neurol Sci; 1981 Aug; 2(3):303-6. PubMed ID: 7341553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Catalepsy in the rat after haloperidol and some new GABA-ergic agents].
    Vamvakidès A
    Agressologie; 1984 Oct; 25(9):1011-6. PubMed ID: 6542324
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex.
    Vincent SL; Adamec E; Sorensen I; Benes FM
    Synapse; 1994 May; 17(1):26-35. PubMed ID: 8042144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain region effects of clozapine on amino acid and monoamine transmission.
    Yamamoto BK; Pehek EA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():8-14. PubMed ID: 7961581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic haloperidol administration enhances the gamma-aminobutyric acid level in the rat striatum without altering the glutamate level.
    Kornhuber J; Kim JS; Kornhuber ME; Kornhuber HH
    Eur Neurol; 1984; 23(4):269-73. PubMed ID: 6541578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic haloperidol and sulpiride treatment induces region-specific changes in tissue levels of putative amino acid transmitters in rat brain.
    Lindefors N; Tossman U; Ungerstedt U
    Neurosci Lett; 1987 Feb; 74(1):90-4. PubMed ID: 2882448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on the modulation of regional brain neurotensin concentrations by antipsychotic drugs: focus on haloperidol and BMY 14802.
    Levant B; Nemeroff CB
    J Pharmacol Exp Ther; 1992 Jul; 262(1):348-55. PubMed ID: 1625208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders.
    Mitsushio H; Takashima M; Mataga N; Toru M
    J Pharmacol Exp Ther; 1988 Jun; 245(3):982-9. PubMed ID: 2455042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAergic supersensitivity within the pars reticulata of the rat substantia nigra following chronic haloperidol administration.
    Frey JM; Ticku MK; Huffman RD
    Brain Res; 1987 Nov; 425(1):73-84. PubMed ID: 3427428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of dopaminergic drugs on the concentrations of PGE2 and PGF2alpha in various brain regions].
    Grasso AA; Millia CC; Rampello L; Reggio A; De Simone D; Bousquet E; Rapisarda E
    Boll Soc Ital Biol Sper; 1983 Jan; 59(1):58-64. PubMed ID: 6573881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tachykinins in the rat substantia nigra: effects of selective dopamine receptor antagonists.
    Oblin A; Zivkovic B
    Fundam Clin Pharmacol; 1991; 5(2):129-38. PubMed ID: 1712746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine.
    Rupniak NM; Prestwich SA; Horton RW; Jenner P; Marsden CD
    J Neural Transm; 1987; 68(1-2):113-25. PubMed ID: 3806083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic haloperidol on dopamine release following microinjection of GABA into the substantia nigra zona reticulata in the rat.
    Kamata K; Sugimoto A; Kameyama T
    Brain Res; 1986 Aug; 380(1):1-6. PubMed ID: 3756464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal and nigral COX-2 expression after chronic typical and atypical neuroleptic administration in rats.
    Marin C; Saldaña M; Roca-Ferrer J; Bonastre M; Aguilar E; Mullol J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):678-82. PubMed ID: 17289239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.